Promoting a Healthier Bangladesh with Regulated Tobacco Harm Reduction Alternatives

BENDSTA stands at the forefront of tobacco harm reduction (THR) advocacy, supporting Bangladesh’s move towards safer nicotine alternatives like vaping. Join us as we work towards creating accessible, scientifically-backed alternatives to smoking that benefit both health and economy.

Black and white image of audience with hands raised, capturing concert energy.

Towards a Healthier Bangladesh

Embracing Tobacco Harm Reduction and Vaping Solutions

We envision a healthier Bangladesh through the responsible integration of THR solutions, including ENDS products. Our mission is to work collaboratively with policymakers, industry, and health experts to ensure a future where adult smokers can choose safer alternatives, supporting a reduction in tobacco-related diseases and deaths. A future where Bangladesh recognizes vaping as a sector in its own right, governed by transparent, science-based policies that support both public health and economic growth. BENDSTA strives to create a regulatory framework that meets the needs of the Tobacco Harm Reduction industry and its stakeholders, providing safer alternatives from the death trap of traditional tobacco use.

Mission

To support the availability, responsible regulation, and public understanding of scientifically-validated harm reduction products in Bangladesh, creating a safer, healthier society.

Vision

A future where Bangladesh is tobacco-free, with access to safer, regulated alternatives that improve health outcomes and reduce smoking-related harm.

About Us

Founded in 2020, BENDSTA (Bangladesh Electronic Nicotine Delivery System Traders Association) was created to support a regulated, responsible approach to tobacco harm reduction in Bangladesh. Recognizing the harm caused by traditional tobacco products, our members united to advocate for safer alternatives, engaging policymakers, health professionals, and the public to establish BENDSTA as a prominent representative in this field.

Join us

Uncategorized

24 December 2024

An Overview of Benefits and Harm Reduction Potential of Vaping

In the ongoing fight against smoking-related diseases, tobacco...

Uncategorized

24 December 2024

Providing Safer Alternatives from the Death Trap of Traditional Tobacco Use

Tobacco use remains one of the leading causes of preventable...

Uncategorized

24 December 2024

Why Vaping Works Best as a Tobacco Harm Reduction (THR) Tool

In the ongoing battle against smoking-related diseases, tobacco...

Uncategorized

24 December 2024

Nicotine Replacement Therapy (NRT): A Vital Step Towards Quitting Smoking

Quitting smoking is a formidable challenge for many people around...

Market Insights

Market Size & Economic Impact:

While the exact valuation of Bangladesh’s ENDS market is undetermined due to limited formal market assessments,While precise current valuation figures are challenging to determine, it’s estimated that Bangladesh’s vaping market has grown significantly, reaching hundreds of millions in local currency due to the increasing demand for safer alternatives to traditional tobacco. It is projected to grow annually by 1.99% from 2024 to 2029 due to increased awareness and demand for safer alternatives. The ENDS (Electronic Nicotine Delivery Systems) or vaping industry in Bangladesh, though still emerging, has shown notable growth since its introduction in 2012. The industry includes over 500,000 users and operates through 600+ retail outlets, managed by approximately 200 individual traders. This sector supports over 2,000 middle-class jobs, contributing to the national economy through VAT and taxes and providing stability for small and medium enterprises involved in the import, retail, and distribution of ENDS products. Bangladesh’s ENDS industry presents substantial potential for economic growth, particularly if regulated responsibly to balance public health benefits with economic contributions. Adopting a regulatory framework like that of other countries could further boost its market size and contribute significant revenue through controlled taxation and industry growth.

Market Size & Economic Impact:

Providing Safer Alternatives from the Death Trap of Traditional Tobacco Use:

Traditional tobacco use remains a significant cause of preventable death worldwide, often described as a “death trap” due to its association with severe health issues like cancer, heart disease, and respiratory disorders. In response, public health organizations and harm reduction advocates promote safer alternatives, such as Electronic Nicotine Delivery Systems (ENDS), to offer adult smokers a less harmful option. The Royal College of Physicians emphasizes that vaping is substantially less harmful than smoking. In its report, “Nicotine Without Smoke: Tobacco Harm Reduction,” the organization concludes that ENDS products can significantly reduce smokers’ exposure to the harmful toxins found in burnt tobacco. Royal College of Physicians Report Additionally, Public Health England supports ENDS as a harm reduction tool, stating in its “E-cigarettes: An Evidence Update” that vaping is “at least 95% less harmful than smoking.” This evidence-based perspective underscores vaping’s effectiveness in reducing smokers’ exposure to carcinogens and harmful chemicals associated with tobacco. Public Health England Evidence Update Through BENDSTA’s advocacy, integrating these safer alternatives provides a practical solution for smokers in Bangladesh, helping them transition away from traditional tobacco and supporting public health objectives.

Providing Safer Alternatives from the Death Trap of Traditional Tobacco Use

An Overview of Benefits and Harm Reduction Potential of Vaping:

Vaping, or the use of Electronic Nicotine Delivery Systems (ENDS), has emerged as a modern alternative to traditional smoking, providing nicotine without the harmful byproducts of burning tobacco. Unlike conventional cigarettes, which produce harmful tar, carbon monoxide, and thousands of toxic chemicals, vaping involves heating a liquid—usually containing nicotine, propylene glycol, vegetable glycerin, and flavorings—to create a vapor that the user inhales.

Benefits and Harm Reduction

Public health organizations, including Public Health England, assert that vaping is significantly less harmful than smoking, with studies indicating a reduction of at least 95% of the health risks associated with cigarettes. This reduced risk profile makes vaping an effective tool for Tobacco Harm Reduction (THR), offering smokers a safer alternative and supporting their transition away from traditional tobacco.

Role in Smoking Cessation

Vaping has proven successful as a quitting aid, with research showing it can be more effective than other nicotine replacement therapies, such as patches and gum. The NHS, for instance, highlights vaping’s high success rate for smoking cessation when used with professional support. Vaping also closely mimics the physical sensation of smoking, which helps users manage both the physical and behavioral aspects of nicotine dependence.

Global Perspectives and Regulation

Globally, most countries have implemented regulatory frameworks that support vaping as a harm-reduction tool while maintaining controls to prevent youth access. These policies aim to balance public health interests and the rights of adult smokers to access safer alternatives. These countries showcase successful ENDS regulations that help smokers transition to less harmful products and protect public health, providing a model for how Bangladesh could integrate ENDS into its health strategy :

United Kingdom

The UK promotes vaping for harm reduction, with the National Health Service (NHS) citing that vaping is "at least 95% less harmful than smoking." Strict advertising limits, product safety standards, and public health campaigns help smokers transition to safer alternatives, lowering the national smoking rate. [NHS Vaping Myths and Facts]

New Zealand

New Zealand regulates ENDS to support its “Smokefree 2025” target. With consumer safety, age restrictions, and advertising regulations, New Zealand has achieved a reduction in smoking rates while limiting youth uptake. [New Zealand Ministry of Health]

Canada

Canada’s Tobacco and Vaping Products Act promotes ENDS as a harm reduction tool, requiring health warnings, product safety measures, and youth access restrictions to balance public health objectives with consumer access. [Health Canada]

France

Through strict rules and safety standards, France promotes vaping as a safer alternative to smoking, contributing to national smoking rate reductions. Public Health France also endorses ENDS as part of its public health strategies. [Public Health France]

South Africa

South Africa’s regulated ENDS approach includes quality control and age restrictions, illustrating how harm reduction policies can support public health in developing nations. [South African Department of Health]

Sweden

Known for its successful harm reduction framework, Sweden includes ENDS within its policies, balancing access for adult smokers with stringent advertising restrictions. This model has contributed to one of Europe’s lowest smoking rates. [Global State of Tobacco Harm Reduction Sweden]

Malaysia

Malaysia’s regulatory framework for ENDS includes tax and import regulations that ensure quality and restrict youth access. This balanced approach supports harm reduction, with ENDS seen as an alternative to smoking for adult consumers, potentially reducing national smoking rates. [Malaysian Ministry of Health]

Indonesia

Indonesia is gradually integrating ENDS within its public health policy, with strict regulations. While still in the development phase, Indonesia’s approach to ENDS reflects its commitment to reducing smoking rates through harm reduction strategies. [Indonesian Ministry of Health]

United States

The FDA in the United States regulates ENDS under the Tobacco Control Act, enforcing product safety standards and marketing restrictions while recognizing vaping as a harm reduction tool for smokers. While still cautious, the U.S. supports adult access to regulated ENDS products, helping smokers transition away from cigarettes. [FDA Tobacco Products]

Australia

In Australia, ENDS are available with a prescription, allowing adults to access vaping products through medical channels while minimizing risks associated with unrestricted access. This hybrid approach reflects harm reduction principles while emphasizing consumer safety. [Australian Department of Health - Vaping Regulations]

European Union

The EU’s Tobacco Products Directive (TPD) governs ENDS across member states, ensuring product quality, safety standards. The TPD sets maximum nicotine limits, requires health warnings, and restricts sales to minors, providing a framework that supports THR while prioritizing public health [European Commission - Tobacco Policy]

Other Forms of Tobacco Harm Reduction (THR) and Why Vaping is Most Effective

Tobacco Harm Reduction (THR) includes several approaches beyond vaping that offer adult smokers safer alternatives to traditional cigarettes. Here are some of the most popular THR methods and why vaping is widely considered one of the most effective options:

Snus (Smokeless Tobacco)

Types: Pouches placed between the gum and lip that deliver nicotine without inhaling smoke

How It Works : Snus provides nicotine through absorption via the gum, reducing the need for smoking. Popularity: Snus is especially popular in Sweden, where it has helped achieve one of Europe’s lowest smoking rates alongside vaping. Sweden’s successful model shows that with strict regulations and age restrictions, smokeless alternatives can reduce smoking rates effectively. Effectiveness: Though effective, snus does not replace the behavioral aspect of smoking, which is why it may not fully address the habit for all smokers.

Nicotine Replacement Therapy (NRT)

Types: Patches, gums, lozenges, and nasal sprays

How It Works: NRT products provide controlled doses of nicotine to reduce withdrawal symptoms without the harmful byproducts of combustion found in cigarettes. Popularity: NRT is popular in countries like the United States, UK, and Canada, where health organizations such as the FDA and NHS recommend these methods for smoking cessation.

Heated Tobacco Products (HTPs)

Types: Devices that heat tobacco at lower temperatures than cigarettes (e.g., IQOS, glo, and Ploom)

How It Works: HTPs produce nicotine-containing aerosol without burning the tobacco, thus reducing harmful chemical exposure.

Why Vaping Works Best as a THR Tool

Close Replication of Smoking Behavior

Vaping closely mimics the experience of smoking, offering the familiar hand-to-mouth action and sensation that many smokers find psychologically satisfying. This similarity provides a smoother transition away from smoking, helping users manage both nicotine cravings and the behavioral habits tied to smoking.

Flexibility and Customization

Vaping offers a wide variety of nicotine strengths and flavors, allowing users to tailor their experience based on personal preference. This flexibility empowers users to gradually reduce nicotine intake over time or maintain a level that satisfies their needs, a feature that is unique among THR tools.

Reduced Health Risks

Vaping is consistently shown to be significantly less harmful than smoking. According to Public Health England, vaping is at least 95% safer than smoking, as it avoids the combustion process and the toxic chemicals associated with burning tobacco. This makes it a highly effective THR tool for adults who want a safer option without giving up nicotine.

Eective for Smoking Cessation

Studies indicate that vaping is one of the most effective tools for smoking cessation. Research published by the National Health Service (NHS) and others suggests that vaping, especially when used with professional support, can be more successful than traditional NRTs in helping users quit smoking.

Minimal Risk to Bystanders

Unlike traditional cigarettes, which expose others to harmful secondhand smoke, vaping aerosols have been shown to pose minimal risk to bystanders. This feature aligns with public health goals of protecting non-smokers while allowing smokers to use less harmful alternatives.

Addressing Concerns About Vaping:

Vaping, as a key tool in tobacco harm reduction (THR), has sparked discussions around potential concerns. However, understanding these concerns within the context of evidence-based research reveals that vaping, while not entirely risk-free, is a significantly safer alternative to smoking. Public health organizations worldwide, including Public Health England and the Royal College of Physicians, support vaping as a safer option, with studies showing it to be at least 95% less harmful than traditional cigarettes.

1. Long-Term Health Effects

Concerns about the long-term effects of vaping stem from its relatively recent emergence. However, ongoing studies, particularly from the NHS and other health agencies, consistently show that vaping eliminates the harmful toxins associated with burning tobacco, such as tar and carbon monoxide. The absence of combustion in vaping is a game-changer in harm reduction, as it allows smokers to enjoy nicotine with far fewer risks than smoking.

2. Youth Access and Use

Youth access to vaping products is a valid concern, but responsible regulation can address this effectively. In countries with strict age restrictions, youth access has been successfully controlled without limiting adults’ access to safer alternatives. The vaping community, including BENDSTA, strongly supports age-verification policies, responsible awareness, and regulation that focuses on adult smokers who want a less harmful option.

3. Nicotine Dependency

Nicotine is addictive, but it’s crucial to note that nicotine itself is not the primary cause of smoking-related diseases—these stem from toxic chemicals created by burning tobacco. Vaping provides a cleaner delivery of nicotine without the severe health risks, making it a valuable alternative for adult smokers. Furthermore, vaping allows users to gradually reduce nicotine levels if they choose, offering flexibility for those looking to decrease their dependency.

4. Unregulated Markets and Product Quality

The safety and quality of vaping products vary significantly between regulated and unregulated markets. With a proper regulatory framework, such as those in the UK and Canada, vaping products meet high safety and quality standards, ensuring consumer protection. BENDSTA advocates for similar standards in Bangladesh to make vaping safe and accessible And preventing the risks associated with unregulated, low-quality products.

BENDSTA’s Recommendations for a Regulatory Framework on Electronic Nicotine Delivery Systems (ENDS) to Government Bodies

The Bangladesh Electronic Nicotine Delivery System Traders Association (BENDSTA) appreciates the government’s commitment to public health and the objective of reducing smoking-related illnesses and deaths in Bangladesh. To achieve these goals, BENDSTA advocates for a well-balanced, evidence-based regulatory framework for Electronic Nicotine Delivery Systems (ENDS), including vaping products. The following recommendations outline a comprehensive framework that promotes consumer safety, public health, and economic benefits while providing adult smokers access to safer alternatives.

1. Recognition and Classication of ENDS as a Harm Reduction Tool

Recommendation:

Officially recognize ENDS as a harm reduction tool distinct from traditional combustible tobacco products.

Rationale:

Numerous studies and health organizations, such as Public Health England and the Royal College of Physicians, have shown that ENDS are significantly less harmful than cigarettes. Recognizing them as a safer alternative aligns with international standards in public health and allows for a regulatory framework tailored to the specific characteristics and benefits of ENDS.

3. Age Restrictions and Youth Protection Measures

Recommendation:

Enforce strict age restrictions (e.g., 18+ years) for purchasing and using ENDS products, supported by mandatory ID verification at points of sale and comprehensive retailer training.

Rationale:

Youth protection is critical in any regulatory framework. Establishing age restrictions and enforcing responsible sales practices aligns with international models, ensuring that ENDS are available only to adult consumers. Education and training for retailers further prevent underage access and promote responsible distribution.

5. Health and Safety Standards for E-Liquids and Devices

Recommendation:

Implement rigorous safety standards for e-liquids and ENDS devices, requiring certifications such as Material Safety Data Sheets (MSDS), Restriction of Hazardous Substances (RoHS) compliance, and laboratory testing reports for all e-liquid ingredients.

Rationale:

Ensuring e-liquids and devices meet internationally recognized safety standards protects consumers by reducing the risks associated with exposure to hazardous substances. MSDS certification provides detailed information on the chemical properties, handling, and potential hazards of e-liquids, ensuring consumers and regulators are informed about safety measures. RoHS ensures compliance standards in devices, contributing to consumer and environmental protection. Laboratory testing reports for e-liquids verify ingredient quality and concentration, ensuring the product meets safety standards and does not contain contaminants or harmful additives.

7. Regulation of Distribution Channels

Recommendation:

Establish a controlled licensing system for the distribution of ENDS products, with a requirement that all licensed entities operate through a recognized industry association that advocates for responsible vaping practices.

Rationale:

A licensing system creates accountability within the industry, ensuring that only compliant, quality-assured ENDS products are brought into the market. By requiring licensed distributors to operate through an association dedicated to vaping advocacy, the government can streamline communication, promote responsible industry standards, and maintain effective oversight. An association like BENDSTA can serve as an intermediary, working with government bodies to uphold quality control, ensure member compliance, and advocate for policies that balance public health with the needs of adult consumers.

9. Research and Data Collection on ENDS Usage and Health Outcomes

Recommendation:

Invest in research and data collection on ENDS usage trends, health outcomes, and economic impact in Bangladesh.

Rationale

The evidence-based policy relies on accurate data. Regular research allows policymakers to evaluate the effectiveness of ENDS as a harm reduction tool and adjust regulations as needed. Collaborative research with health institutions ensures that policies remain relevant and benefit from global advancements in THR.

11. Stakeholder Collaboration and Policy Review

Recommendation:

Facilitate ongoing collaboration with relevant stakeholders, including public health officials, ENDS manufacturers, retailers, consumer groups, and harm reduction advocates, with regular policy reviews and updates.

Rationale:

Collaborative regulation ensures that all voices are considered in policymaking. By engaging key stakeholders, the government can develop policies that reflect diverse perspectives and adjust regulations based on emerging evidence and feedback.

2. Product Quality Standards and Safety Protocols

Recommendation:

Establish clear safety and quality standards for ENDS products, including ingredient labeling, manufacturing standards, and product testing requirements.

Rationale:

Ensuring high product quality and safety prevents consumer exposure to harmful contaminants and substandard devices. Clear labeling with ingredient transparency allows consumers to make informed choices, promoting a regulated market with safe, reliable products.

4. Marketing and Advertising Regulations

Recommendation:

Allow responsible advertising and marketing practices focused solely on adult smokers, with clear guidelines to avoid appealing to non-smokers and minors.

Rationale:

Effective regulation allows adult smokers to learn about ENDS as a safer option without promoting their use among non-smokers. Regulated marketing ensures that promotional materials are factual and targets those who can benefit from switching to less harmful alternatives.

6. Comprehensive Product Labeling and Health Warnings

Recommendation:

Require clear labeling for all ENDS products, including nicotine concentration, ingredients, and usage instructions. Include accurate, science-based health warnings.

Rationale:

Transparent labeling empowers consumers to make informed decisions and understand the potential risks associated with nicotine use. Health warnings that accurately reflect the relative risks of vaping versus smoking help communicate harm reduction messages without misleading consumers.

8. Taxation Policies to Encourage Harm Reduction

Recommendation:

Implement a reasonable tax rate on ENDS products that reflects their harm reduction potential, making them more affordable than traditional tobacco products.

Rationale:

Lower taxation on ENDS compared to cigarettes incentivizes smokers to switch to these safer alternatives. A balanced tax structure supports public health by encouraging harm reduction while still contributing to government revenue.

10. Public Awareness and Consumer Education Initiatives

Recommendation:

Develop public health campaigns focused on educating consumers about the relative risks of ENDS versus smoking and the potential benefits of harm reduction.

Rationale:

Informed consumers make better health decisions. Public awareness campaigns funded in part by ENDS industry contributions could educate the public on the benefits of switching to safer alternatives, reduce misinformation, and support a balanced perspective on THR.

A comprehensive regulatory framework for ENDS supports Bangladesh’s goals of reducing
smoking-related harm, protecting public health, and fostering economic growth. BENDSTA believes
these recommendations can provide a balanced approach to regulating ENDS products,
allowing adult smokers access to safer alternatives while ensuring high product standards and youth
protection. By adopting an evidence-based regulatory model, Bangladesh can reduce

tobacco harm and improve the quality of life for millions of its citizens.

Organogram

A clear visual layout showcasing:

BENDSTA Awareness Programs and Seminars

Bangladesh THR Summit 2023

The Bangladesh Tobacco Harm Reduction (THR) Summit 2023 was a landmark event aimed at exploring the development of a regulatory framework for tobacco harm reduction in Bangladesh. This event gathered globally recognized public health experts and stakeholders to discuss safer alternatives to smoking and the benefits of adopting a THR-focused approach in national policy.

Key Participants:

The summit was chaired by prominent THR advocate Dr. Delon Human, who is a prominent global health advocate and medical doctor with extensive experience in tobacco harm reduction, public health policy, and preventive medicine. He has served in leadership roles with international health organizations, including as the former Secretary-General of the World Medical Association. Dr. Human is well-known for his work on promoting safer alternatives to smoking and has advised several governments and health bodies on harm reduction strategies. and featured a lineup of distinguished speakers, including:

Dr. Derek Yach

A global health expert and former WHO executive, Dr. Yach played a key role in developing the WHO’s Framework Convention on Tobacco Control.

Dr. Konstantinos Farsalinos

Greek cardiologist and prominent researcher on vaping’s impact, known for his evidence-based approach to vaping safety.

Prof. Mihaela Răescu

Romanian academics and researchers focused on the effects of smoking on oral health, promoting THR in dental health.

Michael Landl

Director of the World Vapers’ Alliance, representing vapers globally and advocating for reasonable vaping regulations.

Dr. Kgosi Letlape

South African medical leader and THR advocate, former president of South Africa’s Health Professions Council.

Schumann Zaman

Local industry representative (BENDSTA President).

Dr. Marewa Glover

New Zealand public health academic specializing in smoking cessation, especially for indigenous populations.

Federico Fernandez

International THR policy advocate.

The summit also saw attendance from representatives of key government ministries—Industries, Finance, Commerce, and Home Affairs—as well as influential institutions such as the Bangladesh Investment Development Authority (BIDA). This high-level participation highlighted the significance of THR in shaping a public health policy that aligns with Bangladesh’s economic and social priorities.

Highlights

Participants discussed the need for a balanced THR framework that offers safer alternatives to traditional tobacco products while addressing public health concerns. Experts shared insights on international THR practices, scientific evidence supporting reduced-risk products, and regulatory models that prioritize adult access to safer alternatives. The Bangladesh THR Summit 2023 marked a pivotal step towards building awareness and consensus among policymakers, industry leaders, and public health experts, setting the foundation for a sustainable, health-focused approach to tobacco regulation in Bangladesh.